Home
Mumbai Oncocare Center

七月 2026的Mumbai Oncocare Center市场份额分析

MOC Cancer Care & Research Centre is a trusted oncology hospital in Haryana, North India, offering advanced oncology treatment, personalised cancer care, and medical oncology services, delivered by top oncology experts.

健康 > 其他健康相关

域mocindia.co.in

成立年份2018

员工1001 - 5000

年营收--

Mumbai Oncocare Center

Mumbai Oncocare Center（包含公司地区分支机构）

mocindia.co.in

查看更多网站流量和参与度信息

Mumbai Oncocare Center热门域名的总访问量

了解Mumbai Oncocare Center市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

mocindia.co.in20.7K

使用销售情报查看更多信息

Mumbai Oncocare Center热门域名的平均访问时长

分析Mumbai Oncocare Center参与度指标。

过去 3 个月的平均访问时长

子公司明细

mocindia.co.in00:01:11

使用销售情报查看更多信息

Mumbai Oncocare Center热门域名的平均页面浏览量

了解Mumbai Oncocare Center如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

mocindia.co.in1.61

使用销售情报查看更多信息

Mumbai Oncocare Center 排名靠前的竞争对手（按域名）

七月 2026的热门相似网站，按亲和力排名

gacancer.com公司名称Georgia Cancer Specialists员工201 - 500总部美国, 格鲁吉亚, Atlanta年营收$25M - $50M总访问量20.3K健康 > 其他健康相关

Mumbai Oncocare Center 采用的主要技术

这些是排名前 Mumbai Oncocare Center 的顶级域名所使用的网站技术（按行业分列）

小部件 (5)

Twemoji

移动设备 (4)

Meta Viewport

社交 (4)

Instagram

付费广告 (3)

DoubleClick

更多技术

9

查看全部

Mumbai Oncocare Center 的新闻与信号

借助 Similarweb 销售信号提醒，每当在目标受众之中出现新的机会或威胁时，您都会收到所识别出购买信号的每日更新。

新闻Mocindia opens new location in Mumbai, India, Southern Asia, Asia.Strengthening this very belief, MOC Cancer Care & Research Centre has launched its new state-of-the-art facility in Vashi, Navi Mumbai - designed not only to provide advanced treatment but also emotional support to patients and their families.

新闻Elevation Capital invested into Mocindia $18M in Seed on Jul 1st '25.Last year, Everhope Oncology secured $10 million in seed funding, while MOC Cancer Care & Research Centre raised $18 million in a round led by Elevation Capital.

新闻Mocindia received financing of $18M in Series B on Mar 1st '25.MOC Cancer Care & Research Centre, a network of healthcare centres providing services in oncology and haematology, has secured $18 million (Rs 157 crore) in a Series B round of funding led by venture capital firm Elevation Capital.